Skip to main content
OpenTrials
Completed

NCT Number: NCT04508010

Comparison of IVR and CATI Surveys in Bangladesh

This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and computer assisted telephone interviews (CATI) surveys conducted in low-and middle-income (LMIC) setting (Bangladesh) and evaluates how the two survey modalities (IVR and CATI) affect survey metrics, including response, completion and attrition rates.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute of Epidemiology, Disease Control and Research

Dhaka, Bangladesh

About this study

Using random digit dialing (RDD) sampling technique, participants will be randomized to one of two arms : 1) IVR or 2) CATI. Participants in the first study arm will receive an IVR survey. Participants in the second study arm will receive a CATI survey. Each questionnaire contains a set of demographic questions and one non-communicable disease (NCD) module (alcohol, or tobacco, or diet, or physical activity, or blood pressure and diabetes). We will examine contact, response, refusal and cooperation rates and demographic representativeness by each study arm.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in Bengali language

Exclusion criteria

  • Less than 18 years of age

Treatment and study plan

IVR

Other

Participants will receive an IVR survey

CATI

Other

Participants will receive a CATI survey

Primary outcomes

  1. Cooperation Rate #1

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs

  2. Response Rate #4

    Time frame: Time Frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

Secondary outcomes

  1. Contact Rate #2

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

  2. Refusal Rate #2

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns

Sponsors and collaborators

Lead sponsor

Johns Hopkins Bloomberg School of Public Health

Other

Collaborators

  • Institute of Epidemiology, Disease Control and Research

Registry information

Official study title

Comparison of Interactive Voice Response (IVR) and Computer-assisted Telephone Interview (CATI) Mobile Phone Surveys for Non-communicable Disease Risk Factor Surveillance in Bangladesh

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Aug 11, 2020
Registry last updated
Apr 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.